Intravenous OxyContin‐associated thrombotic microangiopathy treated successfully without plasma exchange
- 6 April 2015
- journal article
- case report
- Published by AMPCo in Medical Journal of Australia
- Vol. 202 (6) , 330-331
Abstract
Conservative management avoids the morbidity and costs associated with plasma exchangeKeywords
This publication has 5 references indexed in Scilit:
- Syndromes of Thrombotic MicroangiopathyNew England Journal of Medicine, 2014
- Thrombotic Microangiopathy and Acute Kidney Injury Associated With Intravenous Abuse of an Oral Extended-Release Formulation of Oxymorphone Hydrochloride: Kidney Biopsy Findings and Report of 3 CasesAmerican Journal of Kidney Diseases, 2014
- Successful treatment of intravenously abused oral Opana ER‐induced thrombotic microangiopathy without plasma exchangeAmerican Journal of Hematology, 2014
- The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioidsMedical Journal of Australia, 2013
- Effect of Abuse-Deterrent Formulation of OxyContinNew England Journal of Medicine, 2012